why choose us

First received: February 29, 2024

Clinical Trial: Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia®

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia® Sourced From the European Union and United State

Brief Summary: A Randomized, Double-blind, Controlled, Parallel-group, Single Dose, Three-arm Study to Compare the Pharmacokinetic Similarity of MAB-22 Versus Prolia®

Read more